Skip to content
Disclosery

BOSTON RESEARCH & MANAGEMENT INC: CVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BOSTON RESEARCH & MANAGEMENT INC on CVS, newest first. How the timeline and the estimate are built.

BOSTON RESEARCH & MANAGEMENT INC held 0 CVS shares at 2026-03-31 per its 13F-HR/A filed 2026-08-26.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F/A 0 shares
    Change vs previous 13F -2,539 shares

    13F-HR/A 0001259261-26-000010 filed by BOSTON RESEARCH & MANAGEMENT INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F/A 2,539 shares
    Change vs previous 13F +2,539 shares

    0.05% of the 13F portfolio, value $201,496.

    13F-HR/A 0001259261-26-000012 filed by BOSTON RESEARCH & MANAGEMENT INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F/A 0 shares
    Change vs previous 13F -33,908 shares

    13F-HR/A 0001259261-26-000018 filed by BOSTON RESEARCH & MANAGEMENT INC
    Accepted , ingested

    Exited: the 13F for this period no longer lists the position.

  4. period ended2024-12-31
    13F/A 33,908 shares
    Change vs previous 13F -28,242 shares

    0.37% of the 13F portfolio, value $1,522,131.

    13F-HR/A 0001259261-26-000020 filed by BOSTON RESEARCH & MANAGEMENT INC
    Accepted , ingested

  5. period ended2024-09-30
    13F/A 62,150 shares
    Change vs previous 13F not available

    0.9% of the 13F portfolio, value $3,907,992.

    13F-HR/A 0001259261-26-000022 filed by BOSTON RESEARCH & MANAGEMENT INC
    Accepted , ingested